Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study
Michèlle Rosenzwajg, Randa Salet, Roberta Lorenzon, Nicolas Tchitchek, Alexandra Roux, Claude C.A. Bernard, Jean‐Claude Carel, Caroline Storey, Michel Polak, Jacques Beltrand, Chloé Amouyal, Agnès Hartemann, Pierre Corbeau, Éric Vicaut, Cecile Bibal, Pierre Bougnères, Tú-Anh Tran, David Klatzmann
Topics & Concepts
PlaceboMedicineDiabetes mellitusHuman physiologyType 2 diabetesInternal medicineType 1 diabetesPediatricsEndocrinologyPathologyAlternative medicineDiabetes and associated disordersT-cell and B-cell ImmunologyDiabetes Management and Research